tirzepatide weight loss per month average outperformed semaglutide weight-loss drug results in real world patients, study shows Tirzepatide Before and After Results:

Relationship between semen quality and seminal plasma total carnitine in infertile men

Tirzepatide and Semaglutide are both in the class of drugs known as incretin mimetics but there are some differences between the two

Results of the Phase IIIa REDEFINE 1 trial (NCT05567796) show that a once-weekly combination of cagrilintide and semaglutide (CagriSema) produced unprecedented weight loss in adults with overweight or obesity, according to trial investigators

leptin, glucagon, glucose dependent insulinotropic peptide) 6,39,40,41,42

How could wider access to GLP-1 generics create challenges if regulation and testing do not keep pace

Retatrutide shows potential for greater efficacy through triple-agonism but awaits Phase 3 results Best For Recommendations# Currently Available Treatment# Recommendation : Tirzepatide Reason : FDA-approved and commercially available as Mounjaro/Zepbound with established dosing protocols and post-market safety data Maximum Weight Loss Potential# Recommendation : Retatrutide Reason : Phase 2 data showed 24.2% weight loss at 48 weeks, exceeding tirzepatide's results, though Phase 3 confirmation is pending Non-Alcoholic Fatty Liver Disease# Recommendation : Retatrutide Reason : Glucagon receptor agonism directly promotes hepatic fat oxidation, showing up to 82% liver fat reduction in trials Type 2 Diabetes Management# Recommendation : Tirzepatide Reason : Proven HbA1c reduction with FDA approval specifically for glycemic control in type 2 diabetes Further Reading# Which Is Better For